Abstract:
OBJECTIVE To investigate the distribution of pathogenic bacteria, drug sensitivity and T lymphocyte subsets for hospital-acquired infection in patients with non-small cell lung cancer (NSLC)treated with radio-chemotherapy, and to provide evidence for early intervention and prevention.
METHODS A total of 80 patients with NSLC treated with radio-chemotherapy combined with hospital-acquired infection in China Guihang Corporate 302 Hospital from Jan. 2020 to Mar. 2024 were selected as the infection group, and 85 patients with NSLC treated with radio-chemotherapy without hospital-acquired infection were selected as the non-infection group. The distribution and drug sensitivity of pathogenic bacteria in the infection group were analyzed. The levels of CD3+, CD4+, CD8+, CD4+/CD8+, T helper cell 17 (Th17), regulatory T cell (Treg) and Th17/Treg were compared between the two groups.
RESULTS A total of 91 strains of pathogenic bacteria were detected in the infection group, in which the proportion of gram-negative bacteria was the largest. Klebsiella pneumoniae was the most common gram-negative bacteria isolated, and Staphylococcus aureus was the most common gram-positive bacteria. K. pneumoniae was highly resistant to cefazolin and sensitive to meropenem; S. aureus was highly resistant to penicillin and sensitive to vancomycin. The levels of CD3+, CD4+, CD4+/CD8+ and Treg in the infection group were (62.37±11.25) %, (36.53±9.61) %, (1.43±0.41) and (1.48±0.37) %, respectively, which were lower than those in the non-infection group; while the levels of CD8+, Th17 and Th17/Treg in the infection group were (25.64±4.84) %, (4.67±0.85) % and (3.15±0.78), respectively, which were higher than those in the non-infection group (P < 0.05).
CONCLUSIONS Gram-negative bacteria are the main pathogens in patients with NSLC treated with radio-chemotherapy combined with hospital-aquired infection, whose cellular immune function impaires. Meropenem and vancomycin are recommended for infection caused by K. pneumoniae and S. aureus.